All articles tagged with #civica rx
California will offer state-branded insulin at significantly reduced prices starting January 1, 2024, as part of a state initiative to lower drug costs, with long-acting insulin pens available for $11 each, aiming to improve access for the 3.5 million Californians with diabetes.
California has partnered with nonprofit drug manufacturer Civica Rx to produce affordable, state-branded insulin to rival longtime producers and lower prices for millions of Americans. The partnership aims to be a "game changer" for the 8 million Americans who use insulin to treat diabetes, with a 10-milliliter vial selling for $30. The state-branded insulin could save many patients between $2,000 and $4,000 a year, according to state documents. The product is not expected to be on store shelves until at least next year.